Loading...
Management Ethics [Spring 2011]
Kalia, Sheerin
Kalia, Sheerin
Author(s)
Author(s) (Additional)
Illustrator(s)
Producer(s)
Contributor(s)
Contributor(s) (Other)
Editor(s)
Advisor(s)
Contact(s)
Data Collector(s)
GE Subjects
Collections
Files
Research Projects
Organizational Units
Journal Issue
Online Access
Abstract
"In this issue: - Editorial: Ethics and Access to Medicine. 80% of the world's population does not have access to much-needed medicines – the same medicines that we take for granted in Canada. This lack of access leaves people vulnerable to disease and death caused by pneumonia, malaria, tuberculosis and AIDS. As Canadians, it is difficult to even grasp the reality of this issue. We do not, in our daily lives, come face to face with the human suffering that lack of access to medicine causes. - Moving Toward International Access to Healthcare: Aligning Ethics and Economics. In the 49 lowest income nations, there are fewer access points in the healthcare continuum to accumulate slack and resource wastage, but resources are also scarce and the role and power of a stakeholder such as government may be highly unstable. - Sanofi-aventis and the Economic Imperative of Corporate Social Responsibility. Sanofi-aventis is one of the world’s leading diversified healthcare companies with more than 100,000 employees in 100 countries. Our mission is: "to improve the lives of everyone". To strengthen our commitment to the patient who is at the center of our focus, we created a new Corporate Social Responsibility (CSR) Direction. The goal was to bring together all of sanofi-aventis’ major initiatives in the economic, social and environmental fields, access to medicines, diversity and humanitarian partnerships. - Increasing Access to Medicine and Improving Health in the Developing World. The World Health Organization (WHO) estimates that each year, nearly three million children under five years old die because of diarrhea and pneumonia. In addition, only half of mothers in Africa and Asia have a skilled health worker attend the birth of their babies. This puts these mothers and children at risk for many complications. - The Regulation of Global Trade in Pharmaceuticals. Pharmaceutical innovations are protected by patents granted under national laws. When pharmaceuticals are commercialized internationally, patent protection must be sought in each country of sale or intended destination. Historically, this legal framework led to inconsistent and unpredictable protection, which in turn created barriers to trade, given the differences in legal rules regarding what is patentable, how long patent protection would last and disparities in or lack of enforcement mechanisms."
Note(s)
Topic
Type
Journal
Date
2011
Identifier
ISBN
DOI
Copyright/License
With permission of the license/copyright holder